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Cell-based biosensors offer cheap, portable and simple methods
of detecting molecules of interest but have yet to be truly
adopted commercially. Issues with their performance and
specificity initially slowed the development of cell-based
biosensors. With the development of rational approaches to
tune response curves, the performance of biosensors has
rapidly improved and there are now many biosensors capable
of sensing with the required performance. This has stimulated
an increased interest in biosensors and their commercial
potential. However the reliability, long term stability and
biosecurity of these sensors are still barriers to commercial
application and public acceptance. Research into overcoming
these issues remains active. Here we present the state-of-the-art
tools offered by synthetic biology to allow construction of cell-
based biosensors with customisable performance to meet the
real world requirements in terms of sensitivity and dynamic
range and discuss the research progress to overcome the
challenges in terms of the sensor stability and biosecurity fears.
1. Introduction
Cell-based biosensors harness a cell’s natural ability to sense
and respond to the environment by repurposing its sensing
mechanisms in new genetic contexts, creating cells capable of
detecting and producing a response to a specific molecule of
interest. Cell-based biosensors gained interest as an alternative
method of sensing because they have several advantages over
traditional methods including cost, portability, and the lack of
equipment and trained personnel required for sensing. The
flexibility of cell-based biosensors in terms of the design and
outputs available is another attractive feature because it allows
biosensors to be tailored to the specific requirements for an
application and preferred readouts. Cell-based biosensors have
potential in multiple areas of research, including environmental
monitoring,[1,2] bioproduction,[3,4] biomedical applications in
diagnostics[5,6] and health monitoring.[7,8]
Despite the advantages, the development of successful
commercial cell-based biosensors has been slow due to several
challenges hindering their construction and their ability to
sense targets of interest at the relevant concentrations. For
early cell-based biosensors, optimisation of the initial constructs
to improve the dynamic range and sensitivity was slow as the
process was carried out ad hoc. The limited number of parts
available also hindered development as many desired targets
did not have known parts for sensing. Despite these challenges
some sensors with the required performance were developed.[9]
The development of rational methods to tune biosensor
performance and the increased number of available parts led to
renewed interest in biosensors because the construction and
optimisation has become much quicker. There now exists many
examples of cell-based biosensors which are able to detect
disease markers, drugs, and environmental pollutants at their
relevant concentrations.[1,10,11] Despite the increasing number of
biosensors in the literature capable of sensing relevant
concentrations there are still very few commercial examples.[12]
This is because commercial cell-based biosensors face chal-
lenges in acceptance arising from biosecurity fears, and
concerns over the stability and reliability of the sensors and the
methods for determining results.
This review aims to give an overview into current areas of
potential applications, then examines the state-of-the art
synthetic biology tools developed for improving the response
of biosensors, the current research on expanding the range of
biosensors and discusses the approaches currently being
investigated to overcome the ongoing challenges of stability
and biosecurity. The focus of this review is on prokaryotic cell-
based biosensors and the methods to tune their response.
Other reviews and publications cover the methods of cell-based
biosensor design and response engineering for different
approaches in more depth.[13–18]
2. State-of-the-Art of Cell-Based Biosensor
Applications
Cell-based biosensors have been developed as potential
alternative analytical devices for the detection of a wide range
of molecules in various areas. Key areas have been bioproduc-
tion, medical and environmental monitoring due to the
particular advantages biosensors offer in these areas.
Environmental monitoring has been a focus because
biosensors can give information not only on the presence of
pollutants but also on their bioavailability, which is important
when considering the impact of the pollutant on the environ-
ment. Cell-based biosensors also offer the possibility of remote
testing for a pollutant which is a significant advantage when
testing for dangerous materials such as explosive residue from
mines.[11]
For medical applications cell-based biosensors offer faster
diagnostics than traditional methods, where culture of the
infectious agent is commonly required as well as transport to a
testing lab. More recently with the rise of interest in point-of-
care testing and health monitoring wearable cell-based bio-
sensors have been developed to the proof-of-concept stage.[19]
The development of technologies such as microfluidics also
mean that biosensors can be used in a high throughput manner
which is highly important for identification of new drugs[20] or
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drug resistance.[21,22] Cell-based biosensors also allow the
detection of a pathogen to be linked to downstream processes
such as the production of a treatment.[23]
Bioproduction is a large area of research because it has the
potential to allow the production of commercially important
chemicals in a cheap and environmentally friendly way.
However the yield from bioproduction methods can be highly
variable depending on the cell culture health and metabolite
availability. Recent work has focussed on the development of
biosensors for metabolite availability[24] and the physiological
status of the cells,[3,4] to improve yields and make yields more
similar between different batches.
Food safety applications have also been studied but less so,
with the focus here on the detection of a molecule of interest
which must not to be present in food commonly allergens and
pathogens.
More recently using cell-based biosensors to create func-
tional materials has become an area of focus. These would
allow materials to not only gain functionality but potentially
regenerative abilities.[25] Table 1 highlights the range of areas
for which biosensors have been developed, giving recent
examples.
3. Engineering Biosensing Parts
Cell-based biosensors follow the same general architecture,
outlined in Figure 1, of a sensor encoded within a cell to detect
the input which can then activate the output. This generic
architecture has been employed in a wide range of different
areas of sensing using many different outputs, although optical
detection is the main focus for current biosensors. Synthetic
biology has allowed the rapid construction of whole-cell
biosensors which can be programmed to produce the desired
response.
To be able to construct a biosensor for a target of interest,
parts which can be used to sense and respond to the target of
interest first need to be identified. Initially, identifying parts
which could be used was mostly due to chance. Part mining
has been an important tool for identifying new parts for sensing
molecules of interest. The increasing ease of sequencing has
meant a large increase in the number of bacterial genomes
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Figure 1. Biosensor architecture: A cell-based biosensor works by the input
entering the cell being detected by the sensor component (sensor) of the
genetic circuit which is a gene constitutively expressing a transcription factor
(TF) which then activates the generation of a reporter protein (output) by
binding and activating the promoter responsive to the transcription factor
(PTF).
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available. Bioinformatics tools have been used to search these
genomes for orthologues of known sensing elements by
looking for closely related sequences. Parts have been identified
both through searches based on DNA sequence similarity[39]
and by searching through part labels on protein databases.[40]
Directed evolution has also been used for generating new
parts to build biosensors. Mutagenesis is used to create a library
of mutants which are screened for the desired characteristics.
This process is repeated until the optimal characteristics
possible are obtained. Directed evolution has been successful in
the generation of new or improved protein parts.[41,42] In general
synthetic biology approaches to biosensor construction has not
favoured the use of directed evolution to generate or improve
parts. The generation of rational approaches which are widely
applicable to many different constructs is preferred.
Two-component systems (TCS) are a huge class of proteins
responsible for sensing and responding to signals in nature.[43]
However they have not been frequently used when developing
biosensors.[36] This is due to difficulty in maintaining the activity
of the components when moved into alternative bacterial
species. The output promoters frequently have multiple
methods of regulation, impacting the response. TCS contain a
sensor module which binds to the target activating the kinase
domain. The kinase domain then phosphorylates the response
regulator to activate it resulting in binding to the output
promoter to activate expression. The mechanism is outlined in
Figure 2. Work into developing TCS for use in other contexts
and species has looked at swapping sensor elements and has
been carried out to improve TCS for use in biosensors. Work has
focussed on altering the sensing domain of the sensor kinase so
that the sensor kinase is able to detect different target
inputs.[23,44–46] But the success has been limited due to differ-
ences in the regulation and interactions between different
families. The response regulators of TCS are far more modular
with much higher conservation in structure and regulation
within TCS families, suggesting the DNA binding domains could
be swapped between different TCS to allow different output
promoters to be used, Figure 2b.[47] This would allow the use of
output promoters that are already well characterised and well
understood to be used to control the expression of a reporter.
Being able to easily repurpose TCS into biosensors will greatly
Table 1. Representative applications of cell-based biosensors. The table summarises some of the recent examples of synthetic biology enabled cell-based
biosensors in the literature over different areas of monitoring.
Application Examples References
Environmental monitoring Detection of explosive residue [11]
Heavy metals [1,26–28]
Pesticides [29,30]
Pharmaceuticals [31]
Endocrine disruptors [32]
Hydrocarbons [33,34]
Toxicity assay Whole-cell human toxicity sensor [35]
Diagnostics Quorum sensing molecules for infection [5]
Gut inflammation [7,36]
Sepsis [6]
Antimicrobial resistance [21,22]
Point-of-care monitoring Proof-of-concept wearable device [19]
Treatment Detecting and supressing cholera [23]
Drug screening [20]
Nutrition Zinc monitoring in human serum [8]
Bioproduction Lactate production in cell culture [3]
Cell-based stress [4]
Identification of optimal bioprocess parameters [24]
Food safety Pathogens [37]
Allergens [38]
Functional biomaterials Proof-of-concept biomaterial to detect chemical inducers such as IPTG and DAPG [25]
Figure 2. Bacterial two-component systems for biosensing: a) The sensor
module of the TCS sensor kinase binds to the target resulting in activation of
the kinase domain, the response regulator is then phosphorylated by the
activated kinase domain to activate the response regulator. The response
regulator will then bind to the output promoter (PR) to generate the
response. b) Response regulators containing their cognate receiver domain
(RD) and DNA binding domain (DBD) will bind to their cognate output
promoter (PR), response regulators with swapped DBD will then bind to an
alternative output promoter (PS) which generates a stronger output.
[47]
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expand the range of targets for which parts are already
available.
Antibody derived parts such as nanobodies can be
produced that bind to almost any target, so are a good method
to bind to a target for which transcription factors and
responsive promoters have not been found. These nanobodies
can be combined with other parts to link the binding to the
generation of a response. Split proteins, which when brought
back together are capable of generating a response through
activating transcription or an enzymatic reaction, can be
brought back together through the binding of the target
molecule by adding binding domains onto the split
proteins.[48,49] This method has been used to try and generate
universal cell-based biosensor platforms to speed up develop-
ment and optimisation by using a well understood system and
is highlighted in Figure 3. A second method which uses
antibody derived parts for detection has been developed where
nanobodies can be expressed on the surface of bacterial cells
which after binding to the target of interest result in
agglutination.[50] This method allows molecules which cannot
enter the cell to be detected.
An alternative approach to split proteins is using metabolic
by-products as the molecule which is detected to generate the
response. A metabolic pathway can then be used to generate
this product from the real target of interest, so that this target
can be sensed.[51] The advantage of this method is quick
optimisation as the response circuit chosen is already highly
optimised. Both approaches to creating generic methods of
cell-based biosensing are shown in Figure 3.
Alternative sensing methods not using proteins have also
been developed. DNA and RNA are capable of selectively
binding molecules depending on 3D conformations which can
be linked to outputs.[52] DNA and RNA switches can also be
used for detection to switch on transcription or translation.[53]
4. Tuning a Biosensor’s Response
Early cell-based biosensors showed poor response to target
molecules as they frequently had highly leaky expression with a
small dynamic range and poor sensitivity. These aspects of the
response curve are highlighted in Figure 4. This was a problem
because commonly targets of interest for sensing will be found
in low concentrations and small changes in the concentration
need to be detected. This requires high sensitivity and a good
signal-to-noise ratio which means a good dynamic range is
important. The specificity of early sensors was also an issue as
many natural transcription factors show promiscuity. Biological
samples are highly complex with many different molecules
present that have the potential to affect the response.
Initially cell-based biosensor optimisation was undertaken in
an ad hoc manner, altering different parts of the genetic circuit
and observing the effect. So optimisation methods were specific
to each case. This did not improve approaches for developing
new cell-based biosensors with better characteristics as it
required the process to be repeated for each new sensor.
Synthetic biology has looked to develop rational methods
capable of targeting a specific characteristic of the response
Figure 3. Approaches for universal cell-based biosensor platforms: Universal
biosensors aim to link specific recognition elements to a generic platform to
expand the range of target molecules capable of being sensed through cell-
based biosensors, whilst generating a system that allows quick construction
and optimisation of new cell-based biosensors. a) Split protein biosensor
systems work by adding the ligand binding domain (LBD) to each separate
half of a protein which when brought back together generates a response. i)
Split T7 polymerase (Split T7) is used to activate expression of a reporter
protein from the T7 promoter (PT7).
[48] ii) Split glucose dehydrogenase is used
to control the degradation of glucose releasing electrons which can be
detected through a range of methods.[49] b) The target molecule is broken
down using a natural metabolic pathway (metabolic transducer) into a
metabolic product which can be detected by a transcription factor to
activate expression of a reporter from a responsive promoter (PR).
[51]
Figure 4. Characteristics of a typical biosensor response curve: The dynamic
range is ratio between the minimum and maximum output expression (
max=min). The limit of detection (LOD) is the lowest concentration of the
target which can be detected from the background response. The leaky
expression is the level of reporter present when no target is present. These
characteristics are commonly used to define the response of the biosensor.
The operating range gives the concentrations of target which can be
detected through a change in the output.
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curve. Mathematical modelling has been important in identify-
ing the role specific parts within the sensor play in determining
the response,[54] so that by choosing certain parts the curve
characteristics can be targeted individually.[55] These methods
have allowed more purposeful design and optimisation of cell-
based biosensors by following rules identified from other cell-
based biosensors’ behaviours. The methods identified for
optimising the response of biosensors have focussed on protein
based circuits, but the underlying reasoning also applies to
DNA and RNA based sensors. The focus of the review is on
bacterial cell-based biosensors but the tools outlined for
optimising the response can also be used to optimise
eukaryotic cell-based biosensors, and some examples are cited
throughout the review.
4.1. Lowering the Limit of Detection
The limit of detection (LOD) is important for use in real life
applications because molecules of interest are often present at
very low concentrations therefore the lowest concentration that
can be sensed needs to be able to go below the minimum
concentration to be detected. This ensures that the relevant
concentration range can be detected.
The intracellular concentration of the transcription factor
regulating expression plays a large role in determining the
concentration of the target which can be sensed. Altering the
transcription factor concentration can be used to optimise the
LOD, and depending on whether the sensor is an activator or
repressor will determine whether the optimal response requires
increasing or decreasing the intracellular concentration of the
transcription factor,[56–58] outlined in Figure 5a.
Improving the intracellular concentration of the target will
improve sensitivity as this make more of the target available to
the sensors. This can be achieved by adding or increasing
import machinery outlined in Figure 5b,[26] or by preventing the
export of the target by deleting the cognate export machinery.
4.2. Modulating Dynamic Range
The dynamic range is the ratio between the leaky expression
and the maximum expression of the reporter. Maximising the
dynamic range is important for being able to reliably determine
the result from a biosensor ensuring a good signal-to-noise
ratio. To maximise the difference leaky expression needs to be
minimised whilst increasing the maximum expression as much
as possible.
The promoter responsible for controlling the expression of
the output can be used for optimisation and improving the
dynamic range by altering both the leaky expression and the
maximum expression. Strong promoters will lead to high leaky
expression without a large change in expression on activation,
whilst a weak promoter will give low leaky expression but also
have low maximum expression shown in Figure 6a.[58,59] This is
due to the binding equilibrium between the polymerase and
the promoter. Increasing the binding constant too much means
the polymerase is able to bind well even without the tran-
scription factor whilst the opposite is true for reducing the
binding constant. The translation of the mRNA produced can
also be optimised to improve the final output. A high trans-
lation rate will lead to higher leaky expression as well as
increasing the maximum expression, whilst a low translation
rate will reduce leaky expression but also the maximum
expression shown in Figure 6b.[60,61] The simplest method of
altering the translation rate is to change the RBS strength.
Initially libraries were generated for screening these small parts
and it was possible to explore all the variants. Now these parts
can now be quickly optimised and tested as a result of the
development of standard well characterised parts (http://
parts.igem.org) and can be easily substituted, so increasing the
speed of optimisation. Specific translation rates and the RBS
sequences required to generate these rates can also now be
predicted.[62]
Genetic amplifiers can be used to boost the response of a
cell-based biosensor by using ligand-free transcription factors
which generate strong expression from their cognate promoter
under the control of the promoter responsive to the target. The
amplification methods are shown in Figure 7. The simplest
genetic amplifiers use transcriptional activators which can then
be tuned to control the amplification gain using additional
Figure 5. Tuning biosensor response through optimisation of intracellular
receptor densities: a) By altering the intracellular concentration of the
ligand-responsive allosteric transcription factor (TF) the output from the
response promoter (PR) can be altered. i) For activators, increasing the
concentration of transcription factor can increase output from the response
promoter making it more sensitive to the target molecule. ii) For repressors
reducing the intracellular concentration of the transcription factor can
increase the output from the response promoter making it more sensitive to
the target molecule.[56,57] b) Altering the intracellular concentration of the
target molecule can also be used to alter the response of the biosensor. The
intracellular concentration can be increased by engineering import machi-
nery to increase transport into the cell to increase the response.[26]
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regulators to the amplifier’s promoter, Figure 7a.[1,28,63] Positive
feedback has also been used to increase the gain when
activated, Figure 7bi.[64] This signal amplification also improves
the LOD by maximising the change in response between
different concentrations. Genetic amplifiers are a good generic
method to increase expression. However as any basal expres-
sion will also be amplified, amplification tends to be used after
other optimisation methods. First the leakiness need to be
minimised as much as possible to prevent basal amplification
being an issue. Combinations of genetic amplifiers with
methods for reducing leakiness have been used to maximise
the dynamic range by amplifying the maximal expression whilst
preventing amplification of basal expression Figure 7bii.[1]
4.3. Managing Leakiness
High leaky expression is frequently an issue when developing
cell-based biosensors. There are several methods for reducing
leaky expression which act on transcription and translation of
the reporter, such as the use of degradation tags, antisense
transcription and altering the operator sites.
Degradation tags on the output protein is a simple method
for reducing leakiness post-translationally, shown in Figure 8a.[8]
These increase the turnover of the reporter protein so without
activation of expression the leaky level is kept to a minimum,
but this will also affect the maximum. Changing the strength of
the degradation tag can help optimise this effect. Adding a
cleavage site between the degradation tag and the protein
whilst controlling the expression of the protease using the
responsive promoter can be used so that degradation is
prevented when expression from the responsive promoter is
activated thereby ensuring that only leaky expression results in
Figure 6. Part engineering to optimise dynamic range: a) Anderson collection of promoters (http://parts.igem.org/Promoters/Catalog/Anderson) are well
characterised constitutive promoter sequences of a range of strengths which could be used to replace the   35 and   10 sites of responsive promoters to alter
their behaviour. Different strength promoter sequences will alter the maximum expression and the leakiness. Response curves are shown for activator and
repressor systems.[59] b) Alternative ribosome binding site (RBS) sequences of different strengths can be replaced to alter the response of the biosensors.[60,61]
The response curves for activator and repressor systems with different RBS sequences are shown.
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degradation to minimise the impact on the maximum
expression.[1,65]
Leaky expression can be reduced post-transcriptionally
through antisense transcription where another promoter down-
stream of the protein transcribes the non-coding strand to
produce complementary RNA to the mRNA being transcribed
from the leaky promoter.[66] This can be used to generate
double stranded RNA which can trigger degradation of the RNA
or prevent translation by blocking the ribosome, shown in
Figure 8b. The strength of the promoter used to generate the
antisense RNA will alter how much of the mRNA has
complementary RNA bound, interfering with it being translated.
Antisense transcription can also directly interfere with tran-
scription of the mRNA.
Operator sites can be altered to reduce transcription with-
out activation. For activators where the transcription factor is
able to bind even without the target, decoy binding sites have
been used to direct this binding away from the responsive
promoter.[8] This can reduce leakiness by preventing binding to
the responsive promoter to activate expression. Conversely in
repressors this will reduce the amount of repressor able to bind
to the promoter, shown in Figure 8c. The number of binding
sites will alter how much of the transcription factor is titrated
away.[67] This can also affect the LOD because it changes the
level of available transcription factor. For repressor based
biosensors the operator sites within the promoter can be
optimised to improve the promoter response and reduce leaky
expression from the promoter at high target concentrations.
The position of the operator will alter the strength of the
repression generated, so by moving the position of the
operator potentially the repression can be strengthened or
weakened. Repression is strongest at the core site between   10
and   35 sites, and if there is overlap with one of these
sequences this improves repression further,[59] followed by the
proximal site (downstream of the promoter), then the distal site
upstream of the core site,[68] shown in Figure 8di. Adding
Figure 7. Biological signal amplification to boost dynamic range: Genetic amplifiers are ligand-free ultrasensitive transcription factor and promoter pairs which
have a large output dynamic range and can be linked to sensing transcription factors and promoters with low dynamic ranges to increase them. a) The
simplest architecture of an amplifier is an activator system with high expression where the responsive promoter (PR) is used to control the expression of the
activator (hrpS and hrpR) which then activates the amplifier promoter (PhrpL). The effect of an amplifier on the response curve is shown by the two curves. The
level of amplification (amplification gain) can be tuned by adding another level of regulation to the amplifier through a repressor (hrpV).[63] b) Alternative
architectures can also be used for amplification. i) Positive feedback can be added to increase the amplification on induction placing the amplifier protein
(amp) under the control of the amplifier promoter (Pamp) and the responsive promoter (PR).
[64] ii) Amplifiers have been combined with other techniques to
prevent increased leaky expression due to amplification.[1] The addition of a degradation tag to the output protein (ParsR) reduces basal expression. Whilst the
expression of a protease under the control of the same input promoter can cleave off the degradation tag when the target is present to prevent reduction in
the maximal expression.
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additional operator sites downstream of the promoter can
improve repression if there is still leakiness by acting as a
physical block to the polymerase[69] Figure 8dii. Operator sites
have also been altered in eukaryotic cell-based biosensors to
improve the sensitivity.[70]
5. Increasing Sensing Selectivity
Many natural transcription factors are promiscuous because this
allows cells to respond to more molecules without the require-
ment for sensing proteins for each molecule.[71] Non-specific
sensors are a good method for initial screening of groups of
molecules.[72] However the majority of biosensors need to be
highly specific to the target to ensure the results are reliable
and accurate. Binding to alternative molecules can lead to a
false positive if this alternative still activates the responsive
promoter. Or if the non-specific interaction results in inactiva-
tion of the protein then this can reduce the response of the
sensor leading to inaccurate quantification.
Directed evolution to alter the structure of transcription
factors has also been used to improve the selectivity of
transcription factors by altering the binding pocket. Improving
the binding of a protein to its target has been more successful
than altering the specificity to a new target, but it is still a slow
process.[73] Improving the specificity of a transcription factor
also usually improves the sensitivity of the biosensors because
Figure 8. Approaches to reduce leaky expression: a) Degradation tags (Deg tags) can be used for post-translational reduction of leaky expression. Degradation
tags increase the degradation of the reporter protein and reduce the levels within the cells. The strength of the degradation tag will determine the reduction
in the levels of the reporter protein.[8,61] The two curves show the change in the response curve with a degradation tag (+ Deg tag) or without (  Deg tag) for
activators and repressors. b) A downstream promoter placed on the non-coding strand can be used to produce a complementary RNA to the mRNA to
generate a double stranded complex which is degraded or blocks the ribosome to prevent translation. The level of mRNA prevented from being used in
translation is controlled by the level of complementary RNA which can be altered by changing the strength of the promoter used to express the
complementary RNA.[66] The two curves show the change in the response curve with antisense transcription (+ Antisense transcription) or without ( 
Antisense transcription) for activators and repressors. c) Decoy sites titrate the binding of the transcription factor away from the responsive promoter (PR). For
activator systems this can reduce leakiness by preventing binding of the transcription factor in the absence of target.[8,67] Whilst for repressors this can be used
to reduce the amount of effective repressor. The two curves show the change in the response curve with decoy sites (+ Decoy sites) or without (  Decoy
sites) for activators and repressors. d) For repressors the position and number of operator sites can be altered to improve the efficiency of the repressor to
reduce leaky expression. i) There are three possible sites for the where the operator can be. First the core site (C) is most efficient and its efficiency is
increased when the binding site overlaps with either the   35 or   10 regions.[59] Second is the proximal site (Pro) downstream of the transcription start site
where the repressor can act as a physical block to the polymerase followed by the distal site (Dis).[68] ii) If the initial operator site (Op) cannot provide enough
repression then an additional site can be added downstream to act as a physical ‘roadblock’.[69]
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altering the binding site to bind better tightens the binding of
the ligand to the transcription factor.[73]
Genetic circuits built using logic gates have been used as a
method to improve the selectivity. Where multiple parts exist
capable of sensing a target but with different promiscuity these
can be combined into an AND gate where both sensors need to
be activated to generate the response, Figure 9.[28] Logic gates
can also be used to detect multiple targets of interest[28,74,75]
which are all related to a specific condition of interest. This
approach is useful in diagnostics where changes in multiple
markers is often required.
The identification of more parts which can be used in the
development of biosensors has also helped to improve the
selectivity that can be achieved as more selective parts can be
picked initially for the development of a biosensors.
6. Improving Sensor Stability
In order for cell-based biosensors to meet the requirements for
commercialisation the stability of the sensor within the cell is
highly important. The output of the sensor construct needs to
be maintained despite fluctuations in the environmental
conditions to ensure that the results are considered reliable.
The sensor constructs themselves also need to be stably
maintained within the cells without changes to the construct or
loss of function.
When cell-based biosensors are used to test real samples
and testing is carried out in the environment rather than under
lab based conditions there will be fluctuations in the environ-
mental conditions during the course of sensing. Ensuring that
the sensor is stable and unaffected by these changes is highly
important for their acceptance as a reliable alternative to
current sensors. Regulatory networks built into the genetic
circuits could be used to ensure the response curve is
maintained over different conditions. Autoregulation of a
protein can be used to reduce variability in the expression of
the protein to generate a more consistent concentration of the
protein. This could be used when expressing transcription
factors to ensure that the changes in the concentration of the
transcription factor are limited and so prevent this from
impacting the response of a genetic circuit.[76] More complex
regulatory networks have also been engineered. For example
feedforward loops could be used to ensure stable expression of
the transcription factor due to changes in copy number or
expression from the gene to prevent fluctuations in the
transcription factor concentration altering the response.[77]
The impact of the genetic circuit constructed for sensing on
the cell is important for it to be stably maintained within the
cell. Inserting extra genetic information into a host increases
metabolic load to the cell diverting nutrients and cellular
machinery away from cellular maintenance and growth. If the
genetic circuit uses too much of the cell’s resources this is a
problem for the cell and mutations to reduce or to lose the
circuit will occur. Research into quantifying this load and how
to reduce the load has been important to develop circuits
which minimise their impact on the cell. Notably copy number
is an important consideration with the same circuit on medium
or low copy number plasmid showing drastically different
burdens and output responses.[78] The development of pro-
grammes to model and design genetic circuits that can take
into account the issue of burden to design constructs which
reduce their impact on the cells can help to reduce instability in
the circuits[79]
The long term stability of the entire cell-based sensor to
allow storage between production and use to ensure they can
be mass produced is important to commercialise cell-based
biosensors. Currently synthetic biology has not developed tools
for extending the shelf life of cell-based biosensors although
other approaches have been studied for storing cell-based
biosensors. Both lyophilisation and encapsulation methods
have been studied to generate cell-based biosensors which can
be stored for the required lengths of time needed for
commercialisation. There are many examples of lyophilisation
to store cell-based biosensors[2,8,80,81] however these cells still
require specific storage conditions to maintain their activity at
either 4 °C[80] or   20 °C.[81] Encapsulation or fixation of cells also
allows cells to be stored for longer periods of time whilst
maintaining activity[82–84] but again requires specific storage
conditions.
Bacteria which naturally produce spores can be used to
store the sensor for long time periods as these spores can be
induced to reanimate when the sensor is required,[85] with
sensor activity retained after 12 months under a range of
different conditions including ambient temperature.[86]
Implementation of regulatory networks, such as feedfor-
ward loops, can help to ensure that the output from the
biosensors at a specific concentration of input remains constant
despite fluctuations in environmental conditions keeping the
sensor stable under changing conditions. The increased under-
Figure 9. Integrating multiple responsive promoters to increase sensing
selectivity: An AND logic gate can be used to generate a highly selective
biosensor for zinc. Each zinc responsive promoter responds to another metal
ion, promoter PzraP also responds to lead and the promoter PzntA also
responds to cadmium. The output promoter PhrpL is activated by a protein
complex formed from two different subunits (HrpR and HrpS). By splitting
the expression of these two components under the control of different
target responsive promoters (PzraP and PzntA) this ensures that reporter (GFP)
expression only occurs when both promoters are activated. Activation of
both promoters will only occur in the presence of zinc and not with either of
the non-specific molecules (lead and cadmium).[28]
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standing of how additional DNA affects the cell and its health
allows the impact to be minimised to prevent selection pressure
resulting in loss of sensor function. This shows that the sensor
circuits can be designed and constructed with improved
stability, although the challenge of improving the shelf life of
sensors still needs to be overcome.
7. Addressing Sensor Biosecurity
Concerns over the use of genetically modified organisms and
their escape into the environment continue to hinder the
acceptance of biosensors as an alternative analytical method.
There has been a large body of work devoted to the develop-
ment of control mechanisms within the engineered cells to
prevent the escape of the genetic information and the cells into
the environment.
Toxin/anti-toxin systems where the production of a toxin is
encoded on the plasmid whilst the anti-toxin is encoded in the
genome of the bacteria being used for the cell-based biosensor
is one method to prevent horizontal gene transfer. This
prevents the transfer of the plasmid to other bacteria in the
environment because without the ability to produce the anti-
toxin the plasmid will be lethal to the cell.[87] The use of non-
canonical amino acids is another method to prevent horizontal
gene transfer because other bacteria will not contain these
alternative amino acids so would not recognise them. The most
common approach to using alternative amino acids is to recode
bacteria where one of the stop codons is instead used to insert
a non-natural amino acid. The use of a recoded stop codon also
helps to prevent horizontal gene transfer because obtaining
these genes in an organism which has not been recoded will
result in truncated proteins being produced.[88] This also makes
the cell an auxotroph, only able to produce protein when
supplemented with the non-natural amino acid so can be used
to prevent cell survival if essential genes are recoded.
The development of methods to prevent the escape of the
modified bacteria into the environment has also been studied.
One method is to encode kill switches which would result in
the death of the cells if they escaped. Multiple different forms
of kill switches have been developed to act in different ways.
The ‘deadman’ switch uses a toggle switch to control the
expression of a toxin so that the toxin was repressed when a
small molecule was present, in this case ATc, but loss of this
input results in death.[89] To ensure that killing is effective fail
safe modules were also added to directly activate the
production of the toxin. Targeted degradation of essential
genes on activation of the kill switch was used to improve the
killing effect. Although a concern is that selection pressure will
result in the loss of the kill switch, work has also developed kill
switches with memory elements to ensure that loss of the kill
switch results in death of the cells. This uses a toxin/anti-toxin
system where the toxin is not produced when either the
memory element or the input signal for the sensor is present
but if the memory element is lost or there is no input the result
is high expression of the toxin overwhelming the low
expression of the anti-toxin resulting in cell death.[90]
Conditional survival of the cells can also be used to ensure
that the cells are unable to survive without intervention by
users to maintain the cells in the required conditions such as
the ‘passcode’ kill switch.[89] Temperature control of cell survival
has been achieved through controlling the regulation of toxin/
anti-toxin systems so that expression of the toxin is prevented
at a desired temperature but if the temperature drops below
this, such as if the cells have escaped into the environment,
then toxin production rises above what the level of expression
of the anti-toxin can handle and results in cell death.[90]
Combinations of these systems have been used to generate
cells which not only prevent horizontal gene transfer of the
plasmid to other cells but ensure that the cells themselves are
not able to survive in the environment without the addition of
nutrients.[87] In one example the initiators for the origins of
replication of the plasmids are also located on the chromosome
to prevent replication of the plasmid outside of the engineered
host. Essential genes are also deleted to make the cells
auxotrophic and toxin/anti-toxin systems are employed to
prevent horizontal gene transfer. Other layered systems have
been developed based on auxotrophy through regulating
essential genes using small molecules which cannot be
supplemented in the environment through cross feeding to
prevent escape. Multiple genes were chosen to reduce the
chance of escape through mutations. Then biotoxic modules
were also engineered into the cell to ensure that the cells are
not able to persist in the environment.[91] The layering of
multiple controls reduces the chance of escape mutants even
further because several mutations would be required to
deactivate all of the controls.
These control mechanisms have been shown to be able to
prevent escape of cells into the environment and shown to be
stable. This ensures the measures are passed down through
generations and for the entire usage of the cell-based
biosensors these control mechanisms remain present. However
public opinion towards genetically modified organisms is still
highly negative and these biosecurity methods have not been
enough to ensure confidence in genetically modified organisms
for commercialisation. Other methods of biosecurity need to
also be considered such as using a physical barrier to isolate
the engineered bacteria from the environment. This could be
used in combination with engineered controls to add another
layer of biosecurity to help ease fears.
Cell-free transcription and translation systems allow for
genetically encoded biosensors to carry out their sensing
function and produce an output outside of the cell. Such
systems could be used to develop biosensors for commercial-
isation because the lack of replicative machinery ensures that
the biosensor cannot escape into the environment. Although
methods to prevent the genetic information from cell-free
being taken up by cells in the environment will need to be
considered. The generation of a genetic firewall would be
considered the ultimate biocontainment tool by generating
cells which use XNA rather than DNA to ensure that engineered
cells are unable to interact with natural cells.[92]
Most importantly to stop biosecurity fears preventing
commercialisation of cell-based biosensors public acceptance of
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the use of genetically modified organisms is required. Therefore
education and outreach to ease fears and remove regulatory
barriers will be crucial.
8. Summary and Outlook
Many of the early challenges in developing biosensors
surrounding the available parts and tuning the response of the
constructed biosensor have been the focus of research, with
new tools and approaches successfully developed. Tools to
program and alter the response have been developed for each
part of the genetic circuits used for biosensing. This means that
biosensors are now increasingly quick to construct and optimise
as the whole process can be optimised for the particular
detection requirements of the sensor. The ability to automate
the design and optimise design aspects prior to construction
has also helped to speed up the process.
The stability of the sensor and ensuring that results
between different tests are consistent is an ongoing area of
research in cell-based biosensors. Work into understanding and
minimising the impact of sensor circuits on the host cell are
important to ensure that the cells maintain biosensor function.
There is now increased understanding of burden and its causes
which are now taken into consideration. The development of
additional regulation to the sensor designs can be used to
ensure that fluctuations in environmental conditions for the
cell-based biosensors which would affect expression of the
biosensor components do not impact the final result. More
work is needed to develop and improve storage methods and
cell-free freeze drying and spore generation currently seem to
offer the best new approaches. Future work will need to be
directed at achieving storage stability in a commercial viable
manner which is competitive in comparison to alternative
methods available.
Biosecurity has been a large focus and consideration in
synthetic biology research with lots of methods shown to be
able to be stably maintained within the cells and effectively kill
the cells to ensure there is no escape into the environment.
Public acceptance is still an ongoing issue despite significant
progress being made to ensure that cells and the genetic
constructs contained within them are not able to survive within
the environment.
Another important consideration in developing biosensors
commercially is how the results are determined. The potential
advantages of ease of use and use outside of a lab without
specialist equipment were a large factor for the interest in
biosensors. The development of smartphones and advances in
camera sensitivity has allowed them to be used as portable
equipment for detection of reporters found in biosensors. The
main challenge to developing methods for detecting the
response of biosensors is that portable methods are far less
sensitive than lab equipment. Whilst improved data processing
and collection methods have helped to improve the quality and
reliability of the data collected using smartphones, the require-
ments of the biosensors in terms of signal-to-noise ratio and
sensitivity are much higher and require more rigorous optimisa-
tion and characterisation.
Recent works into overcoming the ongoing challenges
show that significant progress has been made into biosecurity
and improving the stability of sensors. Further work is needed
to further improve the stability particularly the long-term shelf
life of cell-based biosensors so that they are able to compete
with current commercial sensors and be seen as a viable
alternative. The output from the biosensor and how the results
from the sensor are determined is another aspect of cell-based
biosensors that still needs to be considered when developing
cell-based biosensors to ensure ease of use which will help
increase uptake of cell-based biosensors as a commercial
alternative.
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